Marc Hedrick, CEO of Plus Therapeutics, discusses the company’s nanoliposome technology, how it works, and why the company is focusing on rare cancers.

Using Nanoliposomes to Make Cancer Therapies Safer and More Effective

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Using Nanoliposomes to Make Cancer Therapies Safer and More Effective

Sign up to save your podcasts

Using Nanoliposomes to Make Cancer Therapies Safer and More Effective

Using Nanoliposomes to Make Cancer Therapies Safer and More Effective